Interstitial lung disease and vascular disease
CC6 Challenging clinical cases
Is it truly pulmonary arterial hypertension?
Clinical
Registration for this session is additional to the congress registration fee and is €122 on site, €110 standard.
Aims : Access educational materials here
The diagnosis of pulmonary arterial hypertension is becoming more complex because patients present with more comorbidities. These comorbidities range from metabolic syndrome to coronary artery disease and/or mild lung parenchymal diseases. The aim of this session is to present three different cases of patients who were referred for treatment of PAH that may have developed via different pathophysiological mechanisms.
Target audience :
Clinician, Emergency medicine doctor, Fellow, General practitioner, Intensivist/critical care physician, Junior member, Nurse, Patient, Pharmaceutical industry representative, Pulmonologist, Radiologist, Resident, Researcher, Respiratory physician, Respiratory therapist, Scientist, Student, Trainee
Case 1: Is it lung parenchyma-associated pulmonary hypertension or PAH?
J. Barberà Mir(Barcelona, Spain)
COI
1
3137
Case 2: Is it left ventricular dysfunction or PAH?
J. Vachiery(Bruxelles, Belgium)
COI
2
3138
Case 3: Is it a systemic disorder or PAH?
S. Gaine(Dublin, Ireland)
COI
3
3139
. . .